Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging
|
provides method of treating and imaging EBV-associated cancers.
Treating and imaging EBV-associated cancers
detection diagnosis
This invention provides a nucleus-permeable small-molecule inhibitor, L2P4 (where L2 is 4-(4-(Diethylamino)styryl)-N-carboxymethylpyridinium chloride and P4 is an amino acid sequence comprising CAhxYFMVFGGRrRK and they were coupled through amide bond) and synthesis thereof, which effectively targets the dimerization interface of EBNA1, a critical process for the growth of EBVs and the associated tumors. The present invention also provides method of treating and imaging EBV-associated cancers.
Licensing
US
24/04/2017 00:00:00
15/495,971
A61K/51/00
CN, TW, EP
香港
